星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=2217689, encodeId=bca0221e689a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;干细胞;疾病机理 经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Wed Jul 31 10:07:38 CST 2024, time=20小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2215672, encodeId=272e22156e230, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：增殖;cell proliferation;细胞增殖 经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fa9326563, createdName=ms8000000116100122, createdTime=Thu Jul 18 22:10:18 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

20小时前 ms3000000226534790 来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;干细胞;疾病机理
经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217689, encodeId=bca0221e689a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;干细胞;疾病机理 经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Wed Jul 31 10:07:38 CST 2024, time=20小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2215672, encodeId=272e22156e230, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：增殖;cell proliferation;细胞增殖 经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fa9326563, createdName=ms8000000116100122, createdTime=Thu Jul 18 22:10:18 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-07-27 ms1000000907051820 来自河南

请问系统出现ADM:…, under review是送审了吗？

4 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217689, encodeId=bca0221e689a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;干细胞;疾病机理 经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Wed Jul 31 10:07:38 CST 2024, time=20小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2215672, encodeId=272e22156e230, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：增殖;cell proliferation;细胞增殖 经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fa9326563, createdName=ms8000000116100122, createdTime=Thu Jul 18 22:10:18 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-07-18 ms8000000116100122 来自江苏省

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：增殖;cell proliferation;细胞增殖
经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。

14 0

[GetPortalCommentsPageByObjectIdResponse(id=2217689, encodeId=bca0221e689a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;干细胞;疾病机理 经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Wed Jul 31 10:07:38 CST 2024, time=20小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2215672, encodeId=272e22156e230, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：增殖;cell proliferation;细胞增殖 经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fa9326563, createdName=ms8000000116100122, createdTime=Thu Jul 18 22:10:18 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-07-18 meww 来自江苏省

审稿速度:3.0
偏重的研究方向：发育;口腔
经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2217689, encodeId=bca0221e689a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;干细胞;疾病机理 经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Wed Jul 31 10:07:38 CST 2024, time=20小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2215672, encodeId=272e22156e230, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：增殖;cell proliferation;细胞增殖 经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fa9326563, createdName=ms8000000116100122, createdTime=Thu Jul 18 22:10:18 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2024-05-09 庸医小王来自湖北省

旧的系统显示了Under review，是送外审了吗？

25 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217689, encodeId=bca0221e689a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;干细胞;疾病机理 经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Wed Jul 31 10:07:38 CST 2024, time=20小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2215672, encodeId=272e22156e230, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：增殖;cell proliferation;细胞增殖 经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fa9326563, createdName=ms8000000116100122, createdTime=Thu Jul 18 22:10:18 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2023-03-07 ms5000001252099123 来自浙江省

2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217689, encodeId=bca0221e689a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;干细胞;疾病机理 经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Wed Jul 31 10:07:38 CST 2024, time=20小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2215672, encodeId=272e22156e230, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：增殖;cell proliferation;细胞增殖 经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fa9326563, createdName=ms8000000116100122, createdTime=Thu Jul 18 22:10:18 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2023-06-27 ms3000000199710851 来自浙江省

偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学
经验分享：外审5个月，4个小修，编辑拒稿。。。

59 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217689, encodeId=bca0221e689a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;干细胞;疾病机理 经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Wed Jul 31 10:07:38 CST 2024, time=20小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2215672, encodeId=272e22156e230, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：增殖;cell proliferation;细胞增殖 经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fa9326563, createdName=ms8000000116100122, createdTime=Thu Jul 18 22:10:18 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2022-11-01 ms6000000988225388

偏重的研究方向：细胞增殖
经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福

84 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217689, encodeId=bca0221e689a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;干细胞;疾病机理 经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Wed Jul 31 10:07:38 CST 2024, time=20小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2215672, encodeId=272e22156e230, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：增殖;cell proliferation;细胞增殖 经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fa9326563, createdName=ms8000000116100122, createdTime=Thu Jul 18 22:10:18 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2022-08-07 COCO-么么哒

2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept

99 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2217689, encodeId=bca0221e689a4, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;干细胞;疾病机理 经验分享：刚接收一篇，整体效率蛮高的，全程历时3个月左右，审稿人和编辑都很专业，遇到修回时间不够，发邮件也会很快回复延期。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19848860020, createdName=ms3000000226534790, createdTime=Wed Jul 31 10:07:38 CST 2024, time=20小时前, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2217093, encodeId=22dd221e093cb, content=请问系统出现ADM:…, under review是送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Sat Jul 27 16:35:09 CST 2024, time=2024-07-27, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2215672, encodeId=272e22156e230, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：增殖;cell proliferation;细胞增殖 经验分享：cell proliferation千万不要投，没有关系，千万不要投，太吃亏了一直压着你的文章，最后给你拒稿，我已经吃过亏了，友友们一定要听劝，今年全是关系户。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8fa9326563, createdName=ms8000000116100122, createdTime=Thu Jul 18 22:10:18 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215532, encodeId=3a732215532ca, content=审稿速度:3.0 偏重的研究方向：发育;口腔 经验分享：刚投稿就变成Under review，此状态持续了8周。写信问编辑，编辑回复审稿人意见已经收齐，此后又等了3周无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=t34IBhkqRnOTGcWEQznTlg&s=100&t=1557405456, createdBy=ffff5193366, createdName=meww, createdTime=Thu Jul 18 08:26:53 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港)]

2023-09-19 ms8000000172957012 来自香港

偏重的研究方向：发育
经验分享：投稿的友友们，
我是9.17 投稿
9.18 分配编辑
9.19 Under review
我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~

72 11

展开11条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务